Aberrant post-translational modification pathways of EAAT1/GLAST and EAAT2/GLT-1 are associated with the pathogenesis of ALS (Diaper et al., 2013; Pajarillo et al., 2019; Hirschberg et al., 2021). This evidence concerns the gene SLC1A3 and amyotrophic lateral sclerosis.